MedPath
FDA Approval

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
DIRECT RX
DUNS: 079254320
Effective Date
January 21, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Neomycin(3.5 mg in 1 g)
Dexamethasone(1 mg in 1 g)
Polymyxin B(10000 [USP'U] in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

DIRECT RX

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

DIRECT RX

DIRECT RX

DIRECT RX

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Product Details

NDC Product Code
61919-113
Application Number
ANDA062938
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
January 21, 2020
NeomycinActive
Code: 057Y626693Class: ACTIMQuantity: 3.5 mg in 1 g
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 g
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
Code: 19371312D4Class: ACTIMQuantity: 10000 [USP'U] in 1 g
PETROLATUMInactive
Code: 4T6H12BN9UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath